We studied the extent to which patient characteristics influenced outcome in childhood idiopathic thrombocytopenic purpura in a historical cohort of 289 children over a 20 year period . Outcome was classified as acute or chronic depending on whether the platelet count had returned to normal (150x 109/l) by six months after diagnosis. Fifty three cases (18%) had chronic idiopathic thrombocytopenic purpura.
L G Robb, K Tiedeman Abstract We studied the extent to which patient characteristics influenced outcome in childhood idiopathic thrombocytopenic purpura in a historical cohort of 289 children over a 20 year period . Outcome was classified as acute or chronic depending on whether the platelet count had returned to normal (150x 109/l) by six months after diagnosis. Fifty three cases (18%) had chronic idiopathic thrombocytopenic purpura.
The likelihood of chronic disease was determined by logistic regression analysis of five patient variables: age, sex, season of onset of symptoms, history of recent viral illness, and duration of symptoms at presentation. A history of symptoms of >14 days at presentation, adjusted for the other variables, was strongly predictive of chronic idiopathic thrombocytopenic purpura; the other variables did not significantly affect outcome.
At 28 days after diagnosis 138 (47%) of the study cohort had normal platelet counts. Children whose platelet counts were <150x109/l had a threefold risk of progressing to chronic idiopathic thrombocytopenic purpura, which increased to fivefold if counts were <50x 109/l. Two thirds of patients in the chronic group, irrespective of treatment, remained thrombocytopenic two years after diagnosis.
We conclude that a history of symptoms for greater than two weeks at presentation is strongly predictive of chronic idiopathic thrombocytopenic purpura. If platelet counts are subnormal 28 days after diagnosis the risk of chronic idiopathic thrombocytopenic purpura is increased with prolonged thrombocytopenia being very likely if platelet counts remain low three months after diagnosis.
Childhood idiopathic thrombocytopenic purpura has a low morbidity and mortality and in between 70% to 90% of cases is a self limited illness.`'3 The disease is traditionally divided into two groups: acute and chronic. The division is usually made on the basis of the duration of documented thrombocytopenia with children with platelet counts <150x 109/l at six months being classified as chronic. 4 for more than six months after presentation. We had intended to include the platelet count at diagnosis in our analysis but had to discard this variable because 98% of our study cohort had initial platelet counts <20x 109/l.
Initially a crude odds ratio was calculated for the contribution of each variable to outcome. Exact confidence intervals and, where applicable, trend tests were also determined. The odds ratio gives an estimate of disease (outcome) probability for a particular exposure (variable) and approximates the relative risk (in this study of the child going on to chronic idiopathic thrombocytopenic purpura). In order to produce an estimate of the effects of interest, which was more precise and less biased by confounding, unconditional logistic regression12 was carried out using the Egret software package. 13
Results
Of the 289 children with idiopathic thrombocytopenic purpura in our study, 236 Table 2 gives crude and adjusted odds ratios for the likelihood of having chronic idiopathic thrombocytopenic purpura if platelet counts were <50x109/1 or <150x109/l at 28 days and three months after presentation. For the analyses at three months, duration of symptoms, fReference value for all odds ratios is first variable category. Splenectomy was performed in 33 cases; in seven it was performed less than six months after diagnosis because of fulminant disease which failed to respond to high dose steroids, and in 26 cases the surgery was delayed for greater than six months after diagnosis. The idiopathic thrombocytopenic purpura resolved in all seven patients who had surgery less than six months after diagnosis and in 16 of those operated on after six months. There were no perioperative complications or long term complications, such as septicaemia, after a mean follow up of 4 4 years (range 0 5-8 years). After the introduction of intravenous gammaglobulin in 1985 no further early splenectomies were performed. The timing of splenectomy in the 26 patients with chronic idiopathic thrombocytopenic purpura varied widely, the average being 16 months after diagnosis (range 9-36 months). The mean age at which surgery was performed was nine years (range 7-14 years). Indications for splenectomy in this group were predominantly for persistent platelet counts of <SOx 109/1 with ongoing skin bleeding and need for restriction of physical activities.
COMPLICATIONS
Skin bleeding alone was the only abnormal sign at presentation in 173 (60%) cases, the other 116 also had mucosal bleeding. Eight patients had haematemesis and melaena. Blood transfusions were given in less than 5% of patients. Only three of the children with chronic idiopathic thrombocytopenic purpura required readmission to the Royal Children's Hospital for problems related to thrombocytopenia, other than for gammaglobulin infusion or splenectomy.
Two of these patients who were readmitted with chronic idiopathic thrombocytopenic purpura died of cerebral haemorrhage, as discussed below; the other child was admitted for bedrest because of continued severe bruising and epistaxis.
Three children (1%) died of intracranial haemorrhage, all in the period before the availability of gammaglobulin. Each of these patients had had a bone marrow examination that was consistent with idiopathic thrombocytopenic purpura. The first was a 9 month old boy who presented with a five day history of bruising, petechiae and gum bleeding in association with a respiratory tract infection. He was started on steroids but platelet counts were still <5 x 109/1 four weeks after diagnosis. One week later he fell and hit his head sustaining a large subdural haematoma. Surgical evacuation was followed by uncontrollable fatal haemorrhage. The second death occurred in a girl of 3-8 years who was first seen with a long history of recurrent epistaxis and of two weeks of skin bruising. Despite steroid administration platelet counts remained <5 x 109/1 over the next eight months.
Requests for permission for splenectomy were refused. Eleven months after diagnosis she was admitted with massive oral and skin bruising and haematemesis and died before splenectomy could be undertaken. Necropsy confirmed intracranial haemorrhage. The other death was a 4 year old girl who presented with four months of excessive bruising. Steroids were given and the platelet count had returned to normal by day 14 and remained so after weaning from steroids at one month. Two further courses of steroids were administered at nine and 16 months when the platelet count again fell to <lOx 109/1 and bruising recurred. A splenectomy was performed at 18 months and there was a transient rise in platelet counts to normal but three months later the count was 15 x 109/1. The count returned to normal when steroids were again given. After a further two months steroids were weaned and six weeks later the child had a brief gastroenteritis like illness and suffered a fatal cerebral haemorrhage.
Discussion
In this historical cohort study of childhood idiopathic thrombocytopenic purpura, 53 (18%) of the children reviewed had continuing thrombocytopenia six months after presentation. The mortality rate was 1%, with one death from intracranial haemorrhage occurring at eight weeks after diagnosis and two deaths from intracranial haemorrhage occurring during the chronic phase of the illness. These figures are similar to those found in previous studies. 1-3 15 The benign nature of acute and chronic childhood idiopathic thrombocytopenic purpura, aside from the small ongoing risk of intracranial haemorrhage, is generally recognised.4 8 Major medical complications in our cohort were few, as indicated by the small number of readmissions, other than for treatment, for problems related to thrombocytopenia. The exclusion of tertiary referred patients and the role of the Royal Children's Hospital as the only major paediatric hospital in the study community minimised selection bias towards the chronic idiopathic thrombocytopenic purpura group.
Remission after splenectomy occurred in 23 out of 33 (70%) cases, a figure similar to that reported elsewhere.5 10 The 100% remission rate in children splenectomised early in the course of their illness reflects the differences in the indications for this procedure between the acute and chronic groups. In the former group splenectomy was usually undertaken because of severity rather than chronicity of disease and, had it been possible to avoid the surgery, spontaneous remission may well have occurred.
Early splenectomy as a treatment for severe, life threatening haemorrhage may become even less common now that gammaglobulin is available.
In our search for patient characteristics at presentation that were predictive of chronic idiopathic thrombocytopenic purpura we noted that patients tended to separate into two groups-those who took many days to present in whom onset of bruising was gradual and progressive and mucosal bleeding was less common, and those who presented early, often on the day of symptom onset and who had dramatic, widespread ecchymoses and bleeding. We calculated an adjusted odds ratio of 14-9 for a history of symptoms for greater than 14 days at presentation to the Royal Children's Hospital indicating a strong association between this variable and eventual chronic outcome. The positive trend test showed that if symptoms had been present for between one and two weeks there was also an increased risk of chronicity. Whether these two groups with differing modes of onset of thrombocytopenic symptoms represent disease subtypes with different pathogenesis is not known. Walker and Walker also used the criterion of a history of bleeding for >14 days at presentation to subdivide their patients in a long term follow up study of childhood idiopathic thrombocytopenic purpura.6 As in our study, they found the two groups of patients differed considerably in their outcome, with 91% of the group with symptoms for >14 days of symptoms remitting spontaneously compared with 36% of the group with longer symptom histories.
Associated viral illness, sex of the patient, and season of onset were not predictive of outcome when adjusted odds ratios were calculated. The numbers in the oldest age group were small and the study showed a trend towards greater risk of chronicity with increasing age, although odds ratios were not significant.
A total of 218 (75%) of the total cohort had normal platelet counts three months after diagnosis, with nearly all the children who were classified as having acute idiopathic thrombocytopenic purpura having recovered. Of the children classified as having chronic idiopathic thrombocytopenic purpura on the basis of six months of thrombocytopenia, two thirds, irrespective of treatment, still had thrombocytopenia two years after diagnosis. Recovery was spontaneous in a few and occurred after splenectomy in others. Is there a time short of six months when the course of idiopathic thrombocytopenic purpura in children might be predicted? Our analysis documented that at 28 days the risk of chronic disease was trebled in the group with platelet counts between 50 and 150x 109/1 and five times as likely if counts were <50x 109/1. When early treatment with gammaglobulin is instituted other factors such as initial response to treatment and time to relapse of the platelet count may provide additional useful information regarding long term outcome; to our knowledge such information is not yet available.
The conclusions that may be drawn from this study are that, of the five patient characteristics that we studied which were thought to be related to outcome in childhood idiopathic thrombocytopenic purpura, only symptoms for >14 days at presentation was useful in prediction of chronicity when confounding between variables was accounted for in the analysis. We did not demonstrate clear predictive value for age greater than 10 years at diagnosis but analysis was limited by small sample sizes for the older age groups.
The study also established that ongoing subnormal platelet counts 28 days after diagnosis increased the risk of prolonged thrombocytopenia. This risk was greater in the group with very low platelet counts. Most of our cohort had normal platelet counts by three months after diagnosis. If they did not, continuing thrombocytopenia was likely. This information may be useful to paediatricians managing children with idiopathic thrombocytopenic purpura for counselling patients and their parents and in planning treatment. 
